Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Muscle Contractility in Hypokalemic Periodic Paralysis.
Holm-Yildiz S, Krag T, Dysgaard T, Pedersen BS, Witting N, Kodal LS, Kannuberg L, Pedersen JJ, Andersen RK, Lyu Z, Aagaard MM, Vissing CR, Dahlqvist J, Løkken N, Poulsen NS, Vissing J. Holm-Yildiz S, et al. Muscle Nerve. 2024 Dec 24. doi: 10.1002/mus.28330. Online ahead of print. Muscle Nerve. 2024. PMID: 39719667
Quality of life in hypokalemic periodic paralysis - a survey.
Holm-Yildiz S, Krag T, Dysgaard T, Pedersen BS, Medeiros E, Vissing J. Holm-Yildiz S, et al. Neuromuscul Disord. 2024 Aug;41:24-28. doi: 10.1016/j.nmd.2024.05.012. Epub 2024 May 29. Neuromuscul Disord. 2024. PMID: 38870649 Free article.
Humoral immune response to COVID-19 vaccine in patients with myasthenia gravis.
Holm-Yildiz S, Dysgaard T, Krag T, Pedersen BS, Hamm SR, Pérez-Alós L, Hansen CB, Pries-Heje MM, Heftdal LD, Hasselbalch RB, Fogh K, Madsen JR, Frikke-Schmidt R, Hilsted LM, Sørensen E, Ostrowski SR, Bundgaard H, Garred P, Iversen K, Nielsen SD, Vissing J. Holm-Yildiz S, et al. J Neuroimmunol. 2023 Nov 15;384:578215. doi: 10.1016/j.jneuroim.2023.578215. Epub 2023 Sep 28. J Neuroimmunol. 2023. PMID: 37797472 Free article.
Hypokalemic periodic paralysis: a 3-year follow-up study.
Holm-Yildiz S, Krag T, Witting N, Pedersen BS, Dysgaard T, Sloth L, Pedersen J, Kjær R, Kannuberg L, Dahlqvist J, de Stricker Borch J, Solheim T, Fornander F, Eisum AS, Vissing J. Holm-Yildiz S, et al. J Neurol. 2023 Dec;270(12):6057-6063. doi: 10.1007/s00415-023-11964-z. Epub 2023 Sep 1. J Neurol. 2023. PMID: 37656291 Free PMC article.
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study.
Bril V, Drużdż A, Grosskreutz J, Habib AA, Mantegazza R, Sacconi S, Utsugisawa K, Vissing J, Vu T, Boehnlein M, Bozorg A, Gayfieva M, Greve B, Woltering F, Kaminski HJ; MG0003 study team. Bril V, et al. Lancet Neurol. 2023 May;22(5):383-394. doi: 10.1016/S1474-4422(23)00077-7. Lancet Neurol. 2023. PMID: 37059507 Clinical Trial.
Anoctamin-5 related muscle disease: clinical and genetic findings in a large European cohort.
de Bruyn A, Montagnese F, Holm-Yildiz S, Scharff Poulsen N, Stojkovic T, Behin A, Palmio J, Jokela M, De Bleecker JL, de Visser M, van der Kooi AJ, Ten Dam L, Domínguez González C, Maggi L, Gallone A, Kostera-Pruszczyk A, Macias A, Łusakowska A, Nedkova V, Olive M, Álvarez-Velasco R, Wanschitz J, Paradas C, Mavillard F, Querin G, Fernández-Eulate G, Quinlivan R, Walter MC, Depuydt CE, Udd B, Vissing J, Schoser B, Claeys KG. de Bruyn A, et al. Among authors: holm yildiz s. Brain. 2023 Sep 1;146(9):3800-3815. doi: 10.1093/brain/awad088. Brain. 2023. PMID: 36913258
20 results